Journal of Next Generation Sequencing & Applications

ISSN - 2469-9853

+44 1250400002

Matthew J Marton

Matthew J Marton

Translational Biomarkers, Merck and Co., Inc., Rahway, NJ 07065, USA

Biography
Matthew J Marton  Translational Biomarkers, Merck and Co., Inc., Rahway, NJ 07065, USA  prognosis might be less sensitive to tumor heterogeneity than RNA-based expression signatures, at least based on the performance and sensitivity of current DNA/RNA profiling technologies.
Research Interest

His research interest includes Drug Manufacturing & Research , Pharmaceuticals , Healthcare.

Relevant Topics

Top